🇺🇸 FDA
Pipeline program

Aglatimagene besadenovec + valacyclovir

PrTK03

Phase 3 mab active

Quick answer

Aglatimagene besadenovec + valacyclovir for Prostate Cancer is a Phase 3 program (mab) at Candel Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Candel Therapeutics
Indication
Prostate Cancer
Phase
Phase 3
Modality
mab
Status
active

Clinical trials